Immunogenicity of an HPV-16 L2 DNA vaccine
Data(s) |
2009
|
---|---|
Resumo |
The ability to elicit cross-neutralizing antibodies makes human papillomavirus (HPV) L2 capsid protein a possible HPV vaccine. We examined and compared the humoral response of mice immunized with a HPV-16 L2 DNA vaccine or with HPV-16 L2 protein. The L2 DNA vaccine elicited a non-neutralizing antibody response unlike the L2 protein. L2 DNA vaccination suppressed the growth of L2-expressing C3 tumor cells, which is a T cell mediated effect, demonstrating that the lack of non-neutralizing antibody induction by L2 DNA was not caused by lack of T cell immunogenicity of the construct. © 2009 Elsevier Ltd. All rights reserved. |
Identificador | |
Relação |
DOI:10.1016/j.vaccine.2009.06.015 Hitzeroth, I. I., Passmore, J. A. S., Shephard, E., Stewart, D., Müller, M., Williamson, A. L., Rybicki, E. P., & Kast, W. M. (2009) Immunogenicity of an HPV-16 L2 DNA vaccine. Vaccine, 27(46), pp. 6432-6434. |
Palavras-Chave | #1.2 protein #DNA vaccine #Human papillomavirus #Immunogenicity |
Tipo |
Journal Article |